Discover real-time Biogen Inc. Common Stock (BIIB) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

Get real-time updates on Biogen Inc. Common Stock (BIIB) stock quotes, trades, and more. Make informed investments with Nasdaq.

Dec 9, 2024 · Analysts have recently evaluated Biogen and provided 12-month price targets. The average target is $241.79, accompanied by a high estimate of $300.00 and a low estimate of …

Jan 21, 2025 · Our analysis of options history for Biogen (NASDAQ:BIIB) revealed 8 unusual trades. Delving into the details, we found 37% of traders were bullish, while 62% showed …

Nov 4, 2024 · A clear picture of Biogen's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their …

4 days ago · Across the recent three months, 18 analysts have shared their insights on Biogen (NASDAQ:BIIB), expressing a variety of opinions spanning from bullish to bearish.

Dec 9, 2024 · Stay up-to-date on Biogen Inc. Common Stock (BIIB) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.

Nov 15, 2024 · Deep-pocketed investors have adopted a bearish approach towards Biogen (NASDAQ:BIIB), and it's something market players shouldn't ignore. Our tracking of public …

Apr 18, 2023 · Biotech giant Biogen (NASDAQ: BIIB) has been trying to develop a successful therapy for Alzheimer's disease (AD) for a long time, and its efforts seem to be about to pay off.

Nov 27, 2024 · Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the January 2025 expiration.